Department of Medicinal Chemistry, Ionis Pharmaceuticals , 2855 Gazelle Court, Carlsbad, California 92010, United States.
J Med Chem. 2016 Nov 10;59(21):9645-9667. doi: 10.1021/acs.jmedchem.6b00551. Epub 2016 Jul 29.
Oligonucleotide-based therapeutics have made rapid progress in the clinic for treatment of a variety of disease indications. Unmodified oligonucleotides are polyanionic macromolecules with poor drug-like properties. Over the past two decades, medicinal chemists have identified a number of chemical modification and conjugation strategies which can improve the nuclease stability, RNA-binding affinity, and pharmacokinetic properties of oligonucleotides for therapeutic applications. In this perspective, we present a summary of the most commonly used nucleobase, sugar and backbone modification, and conjugation strategies used in oligonucleotide medicinal chemistry.
寡核苷酸类药物在临床上治疗多种疾病方面取得了快速进展。未修饰的寡核苷酸是具有较差类药性的多阴离子大分子。在过去的二十年中,药物化学家已经确定了许多化学修饰和缀合策略,可以提高寡核苷酸的核酸酶稳定性、RNA 结合亲和力和药代动力学性质,从而将其应用于治疗。在本观点中,我们总结了寡核苷酸药物化学中最常用的碱基、糖和骨架修饰以及缀合策略。